Professor Prokar Dasgupta Leadership Roles in Universities
Prokar became the first Professor and Chair of Robotic Surgery at KCL and subsequently the Chairman of the King’s-Vattikuti Institute of Robotic Surgery. This has the tripartite mission of clinical, scientific and educational excellence. He lead a large team of clinician-scientists at one of Europe’s highest volume robotic institutes with our fellowship programs being in high demand amongst international graduates.
Prokar established KCL as an Epicentre for robotic surgery, accredited by the European Association of Urology Robotic Surgery Board (ERUS) and the Royal College of Surgeons of England.
Prokar holds adjunct Professorship in the Academic and Education Board of the Apollo Group of Hospitals in India and the honorary Directorship in Robotic Surgery in Apollo Gleaneagles Hospital Kolkata.
He is a member of the academic board of the All India Institute of Medical Sciences (AIIMS), Rishikesh, India’s premier University Hospitals Group. He provides advice on the development and implementation of surgical curricula within India’s rapidly changing education system.
Prokar has been Visiting Surgeon and Professor to Maharajah Gaj Singh II of Jodhpur and advised his team on the modernisation of surgical services.
Prokar has built strong overseas links with Monash University, Australia’s largest University and hosted a number of its students at KCL. He is Visiting Professor to over 50 worldwide institutes particularly in China, Japan, The Netherlands, Italy, Belgium, Canada and USA. He has established multi-million collaborations in Europe, the Far East and Southern China.
Prokar is currently one of few Surgical Chairs within the Medical Research Council Centre for Transplantation at KCL, a vibrant university in Central London with over 6,000 staff and 25,000 students. It has a budget of nearly £800 million and is positioned at 5th for Impact amongst leading universities in the world. The launch of the MedTech Hub at KCL is one of our most ambitious projects with plans to extend into the Warterloo campus at St. Thomas’ Hospital over the next few years with a budget of nearly £110 million.
Charity Roles
Professor Prokar Dasgupta Charity Roles
Prokar is a trustee to The Prostate Cancer Research, UK, which has a primary focus of finding bench to bedside solutions for advanced prostate cancer. This led to the inauguration to the Prostate Cancer Research of excellence at KCL, inaugurated by Sir Derek Jacobi in 2014.
He also supports two other UK charities, The Malcolm Coptcoat Trust as a trustee, to champion surgical innovation and The Urology Foundation as a major fund-raiser. Prokar raises funds through competing in marathon and ultra-distance events.
Prokar is also a trustee to The Prostate Cancer Foundation in Kolkata, India to raise awareness of prostatic diseases in West Bengal. One of its major achievements has been the publication of a blog on the last days of the poet and Nobel Laureate Rabindranath Tagore whose death from prostatic disease had hitherto been largely unknown. This had a major impact with the blog being read and shared over 200,000 times.
Commercial & Industrial Roles
Professor Prokar Dasgupta Commercial & Industrial Roles
Prokar was on the board of Intuitive Surgical as an advisor for many years. This is the world’s leading, multi-billion $ robotics company that has changed the way surgery is practised especially in patients with cancer. As a result robotic assisted radical prostatectomy has grown from a single institution in UK where he pioneered this procedure to >90% of procedures nationally over a 20 year period. He have advised and critically analysed the costs of robotic surgery and especially the societal benefits that it brings worldwide by reducing out of pocket costs.
Continued Commercial & Industrial Roles
Prokar has been on the advisory boards of newer robotic companies – Cambridge Medical Robotics, Medtronics, Auris, Surgenius and Google-Johnson & Johnson. This growing market is likely to increase the access to minimally invasive surgery for patient benefit. He is Chief Scientific Officer for Proximie an augmented reality company with the mission of democratising surgery globally, QrATIv, a medical AI company and serve on the advisory board of Jiva.Ai a UK based start-up, improving radiological diagnoses through machine learning.
He served on the advisory boards of Allergan, manufacturers of Botox, the only FDA approved product and led key trials to assist with its licensing process.
You can find out more about roles here:
Social media accounts
Contact
The London Clinic
145 Harley Street, London
W1G 6BJ